Regulating AI Like a Doctor — FDA's Competency-Based Path for Generative AI Devices
OVERVIEWThe FDA is exploring competency-based regulation for generative AI-enabled medical devices, evaluating AI systems based on demonstrated clinical competency rather than fixed performance specifications. This approach parallels physician licensing and privileging, establishing baseline competency, ongoing monitoring, and scope limitations. The framework addresses the challenge that generative AI systems cannot be fully specified at authorization because they may adapt and improve. Competency-based regulation establishes performance standards, governance requirements, and ongoing monitoring rather than locking down specifications at authorization. This regulatory innovation may become a template for other adaptive AI systems in healthcare, representing a fundamental shift in how FDA regulates systems that learn and change over time. UPDATED: FDA continues developing guidance with input from medical device companies, health systems, and patient advocates, with competency-based frameworks being refined based on feedback. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.